{"cluster": 16, "subcluster": 5, "abstract_summ": "Using single cell RNA profiling (scRNAseq) to assess ACE2 and associated SARS-CoV-2 proteases in healthy living donors (LD) kidneys, diabetic kidney disease (DKD), and in kidney injury during viral infection, ACE2 expression was primarily associated with proximal tubular epithelial cells (PTEC).Since the severe acute respiratory syndrome coronavirus 2 (SARS\u2010CoV\u20102) utilizes human ACE2 as the receptor for entry with subsequent downregulation of ACE2, corneal inflammation in Ace2(\u2212/\u2212) mice may have a similar mechanism with that in COVID\u201019 patients.It has been now clearly established that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing COVID-19, infects the host cell through biding and being internalized with angiotensin converting enzyme 2 (ACE2), a surface protein expressed in a noticeable number of human cells, especially in those of upper and lower respiratory tracts, heart, kidney, testis, adipose tissue, gastrointestinal system and in lymphocytes.Because of these protective effects of ACE2 on chronic underlying diseases and ARDS, the development of spike protein\u2010based vaccine and drugs enhancing ACE2 activity may become one of the most promising approaches for the treatment of COVID\u201019 in the future.In this review, we describe the role of ACE2 in COVID\u201019 pathophysiology, including factors influencing ACE2 expression and activity in relation to COVID\u201019 severity.", "title_summ": "Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?The ACE2\u2010deficient mouse: A model for a cytokine storm\u2010driven inflammationSARS-CoV-2 receptor networks in diabetic kidney disease, BK-Virus nephropathy and COVID-19 associated acute kidney injuryAngiotensin\u2010converting enzyme\u20102 (ACE2), SARS\u2010CoV\u20102 and pathophysiology of coronavirus disease 2019 (COVID\u201019)Angiotensin\u2010converting enzyme 2 in severe acute respiratory syndrome coronavirus and SARS\u2010CoV\u20102: A double\u2010edged sword?Organ\u2010protective effect of angiotensin\u2010converting enzyme 2 and its effect on the prognosis of COVID\u201019Two hits to the renin\u2010angiotensin system may play a key role in severe COVID\u201019", "title_abstract_phrases": "Using single cell RNA profiling (scRNAseq) to assess ACE2 and associated SARS-CoV-2 proteases in healthy living donors (LD) kidneys, diabetic kidney disease (DKD), and in kidney injury during viral infection, ACE2 expression was primarily associated with proximal tubular epithelial cells (PTEC).Since the severe acute respiratory syndrome coronavirus 2 (SARS\u2010CoV\u20102) utilizes human ACE2 as the receptor for entry with subsequent downregulation of ACE2, corneal inflammation in Ace2(\u2212/\u2212) mice may have a similar mechanism with that in COVID\u201019 patients.Functional networks of gene expression signatures are available for further exploration to researchers at HumanBase (hb.flatironinstitute.org/covid-kidney).Angiotensin\u2010converting enzyme\u20102 (ACE2), SARS\u2010CoV\u20102 and pathophysiology of coronavirus disease 2019 (COVID\u201019)Angiotensin\u2010converting enzyme\u20102 (ACE2) has been established as the functional host receptor for severe acute respiratory syndrome coronavirus 2 (SARS\u2010CoV\u20102), the virus responsible for the current devastating worldwide pandemic of coronavirus disease 2019 (COVID\u201019).It has been now clearly established that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus causing COVID-19, infects the host cell through biding and being internalized with angiotensin converting enzyme 2 (ACE2), a surface protein expressed in a noticeable number of human cells, especially in those of upper and lower respiratory tracts, heart, kidney, testis, adipose tissue, gastrointestinal system and in lymphocytes.Because of these protective effects of ACE2 on chronic underlying diseases and ARDS, the development of spike protein\u2010based vaccine and drugs enhancing ACE2 activity may become one of the most promising approaches for the treatment of COVID\u201019 in the future."}